Modulation of osteoclast differentiation and bone resorption by Rho GTPases

References

• Sims NA, Gooi JH. Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol 2008; 19:444 - 51; http://dx.doi.org/10.1016/j.semcdb.2008.07.016; PMID: 18718546
   PubMed Web of Science ®Google Scholar
• Matsuo K, Irie N. Osteoclast-osteoblast communication. Arch Biochem Biophys 2008; 473:201 - 9; http://dx.doi.org/10.1016/j.abb.2008.03.027; PMID: 18406338
   PubMed Web of Science ®Google Scholar
• Lacey DL, Boyle WJ, Simonet WS, Kostenuik PJ, Dougall WC, Sullivan JK, San Martin J, Dansey R. Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat Rev Drug Discov 2012; 11:401 - 19; http://dx.doi.org/10.1038/nrd3705; PMID: 22543469
   PubMed Web of Science ®Google Scholar
• Hall A. Rho family GTPases. Biochem Soc Trans 2012; 40:1378 - 82; http://dx.doi.org/10.1042/BST20120103; PMID: 23176484
   PubMed Web of Science ®Google Scholar
• Rossman KL, Der CJ, Sondek J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 2005; 6:167 - 80; http://dx.doi.org/10.1038/nrm1587; PMID: 15688002
   PubMed Web of Science ®Google Scholar
• Ihara K, Muraguchi S, Kato M, Shimizu T, Shirakawa M, Kuroda S, Kaibuchi K, Hakoshima T. Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue. J Biol Chem 1998; 273:9656 - 66; http://dx.doi.org/10.1074/jbc.273.16.9656; PMID: 9545299
   PubMed Web of Science ®Google Scholar
• Zhang B, Chernoff J, Zheng Y. Interaction of Rac1 with GTPase-activating proteins and putative effectors. A comparison with Cdc42 and RhoA. J Biol Chem 1998; 273:8776 - 82; http://dx.doi.org/10.1074/jbc.273.15.8776; PMID: 9535855
   PubMed Web of Science ®Google Scholar
• Cherfils J, Zeghouf M. Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiol Rev 2013; 93:269 - 309; http://dx.doi.org/10.1152/physrev.00003.2012; PMID: 23303910
   PubMed Web of Science ®Google Scholar
• Aspenström P, Ruusala A, Pacholsky D. Taking Rho GTPases to the next level: the cellular functions of atypical Rho GTPases. Exp Cell Res 2007; 313:3673 - 9; http://dx.doi.org/10.1016/j.yexcr.2007.07.022; PMID: 17850788
   PubMed Web of Science ®Google Scholar
• Zhang DE, Hetherington CJ, Chen HM, Tenen DG. The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol 1994; 14:373 - 81; PMID: 8264604
   PubMed Web of Science ®Google Scholar
• Yoshida S, Setoguchi M, Higuchi Y, Akizuki S, Yamamoto S. Molecular cloning of cDNA encoding MS2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage. Int Immunol 1990; 2:585 - 91; http://dx.doi.org/10.1093/intimm/2.6.585; PMID: 1982220
   PubMed Web of Science ®Google Scholar
• Ross FP, Teitelbaum SL. alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology. Immunol Rev 2005; 208:88 - 105; http://dx.doi.org/10.1111/j.0105-2896.2005.00331.x; PMID: 16313343
   PubMed Web of Science ®Google Scholar
• Ito Y, Teitelbaum SL, Zou W, Zheng Y, Johnson JF, Chappel J, Ross FP, Zhao H. Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization. J Clin Invest 2010; 120:1981 - 93; http://dx.doi.org/10.1172/JCI39650; PMID: 20501942
   PubMed Web of Science ®Google Scholar
• Yavropoulou MP, Yovos JG. Osteoclastogenesis--current knowledge and future perspectives. J Musculoskelet Neuronal Interact 2008; 8:204 - 16; PMID: 18799853
   PubMedGoogle Scholar
• Paternot S, Bockstaele L, Bisteau X, Kooken H, Coulonval K, Roger PP. Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase. Cell Cycle 2010; 9:689 - 99; http://dx.doi.org/10.4161/cc.9.4.10611; PMID: 20107323
   PubMed Web of Science ®Google Scholar
• Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T, Anderson DM, Suda T. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med 1999; 190:1741 - 54; http://dx.doi.org/10.1084/jem.190.12.1741; PMID: 10601350
   PubMed Web of Science ®Google Scholar
• Ogasawara T, Katagiri M, Yamamoto A, Hoshi K, Takato T, Nakamura K, Tanaka S, Okayama H, Kawaguchi H. Osteoclast differentiation by RANKL requires NFkappaB-mediated downregulation of cyclin-dependent kinase 6 (Cdk6). J Bone Miner Res 2004; 19:1128 - 36; http://dx.doi.org/10.1359/jbmr.2004.19.7.1128; PMID: 15176996
   PubMed Web of Science ®Google Scholar
• Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 2011; 17:1231 - 4; http://dx.doi.org/10.1038/nm.2452; PMID: 21909105
   PubMed Web of Science ®Google Scholar
• Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O’Brien CA. Matrix-embedded cells control osteoclast formation. Nat Med 2011; 17:1235 - 41; http://dx.doi.org/10.1038/nm.2448; PMID: 21909103
   PubMed Web of Science ®Google Scholar
• Lee NK, Choi HK, Kim D-K, Lee SY. Rac1 GTPase regulates osteoclast differentiation through TRANCE-induced NFkappa B activation. Mol Cell Biochem 2006; 281:55 - 61; http://dx.doi.org/10.1007/s11010-006-0333-y; PMID: 16328957
   PubMed Web of Science ®Google Scholar
• Mizukami J, Takaesu G, Akatsuka H, Sakurai H, Ninomiya-Tsuji J, Matsumoto K, Sakurai N. Receptor activator of NFkappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. Mol Cell Biol 2002; 22:992 - 1000; http://dx.doi.org/10.1128/MCB.22.4.992-1000.2002; PMID: 11809792
   PubMed Web of Science ®Google Scholar
• Besse A, Lamothe B, Campos AD, Webster WK, Maddineni U, Lin S-C, Wu H, Darnay BG. TAK1-dependent signaling requires functional interaction with TAB2/TAB3. J Biol Chem 2007; 282:3918 - 28; http://dx.doi.org/10.1074/jbc.M608867200; PMID: 17158449
   PubMed Web of Science ®Google Scholar
• Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412:346 - 51; http://dx.doi.org/10.1038/35085597; PMID: 11460167
   PubMed Web of Science ®Google Scholar
• Lamothe B, Lai Y, Xie M, Schneider MD, Darnay BG. TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis. Mol Cell Biol 2013; 33:582 - 95; http://dx.doi.org/10.1128/MCB.01225-12; PMID: 23166301
   PubMed Web of Science ®Google Scholar
• Negishi-Koga T, Takayanagi H. Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol Rev 2009; 231:241 - 56; http://dx.doi.org/10.1111/j.1600-065X.2009.00821.x; PMID: 19754901
   PubMed Web of Science ®Google Scholar
• Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, Iwata T, Ohnishi H, Matozaki T, Kodama T, et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 2004; 428:758 - 63; http://dx.doi.org/10.1038/nature02444; PMID: 15085135
   PubMed Web of Science ®Google Scholar
• Asagiri M, Sato K, Usami T, Ochi S, Nishina H, Yoshida H, Morita I, Wagner EF, Mak TW, Serfling E, et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med 2005; 202:1261 - 9; http://dx.doi.org/10.1084/jem.20051150; PMID: 16275763
   PubMed Web of Science ®Google Scholar
• Danks L, Takayanagi H. Immunology and bone. J Biochem 2013; 154:29 - 39; http://dx.doi.org/10.1093/jb/mvt049; PMID: 23750028
   PubMed Web of Science ®Google Scholar
• Lee NK, Choi YG, Baik JY, Han SY, Jeong D-W, Bae YS, Kim N, Lee SY. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005; 106:852 - 9; http://dx.doi.org/10.1182/blood-2004-09-3662; PMID: 15817678
   PubMed Web of Science ®Google Scholar
• Kim MS, Yang Y-M, Son A, Tian YS, Lee S-I, Kang SW, Muallem S, Shin DM. RANKL-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis. J Biol Chem 2010; 285:6913 - 21; http://dx.doi.org/10.1074/jbc.M109.051557; PMID: 20048168
   PubMed Web of Science ®Google Scholar
• Wang Y, Lebowitz D, Sun C, Thang H, Grynpas MD, Glogauer M. Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis. J Bone Miner Res 2008; 23:260 - 70; http://dx.doi.org/10.1359/jbmr.071013; PMID: 17922611
   PubMed Web of Science ®Google Scholar
• Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation. Bone 2007; 40:251 - 64; http://dx.doi.org/10.1016/j.bone.2006.09.023; PMID: 17098490
   PubMed Web of Science ®Google Scholar
• Feng H, Cheng T, Steer JH, Joyce DA, Pavlos NJ, Leong C, Kular J, Liu J, Feng X, Zheng MH, et al. Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis. J Biol Chem 2009; 284:14667 - 76; http://dx.doi.org/10.1074/jbc.M901670200; PMID: 19321441
   PubMed Web of Science ®Google Scholar
• Lu S-Y, Li M, Lin Y-L. Mitf induction by RANKL is critical for osteoclastogenesis. Mol Biol Cell 2010; 21:1763 - 71; http://dx.doi.org/10.1091/mbc.E09-07-0584; PMID: 20357005
   PubMed Web of Science ®Google Scholar
• Mansky KC, Sankar U, Han J, Ostrowski MC. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NFkappa B ligand signaling. J Biol Chem 2002; 277:11077 - 83; http://dx.doi.org/10.1074/jbc.M111696200; PMID: 11792706
   PubMed Web of Science ®Google Scholar
• Sharma SM, Bronisz A, Hu R, Patel K, Mansky KC, Sif S, Ostrowski MC. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. J Biol Chem 2007; 282:15921 - 9; http://dx.doi.org/10.1074/jbc.M609723200; PMID: 17403683
   PubMed Web of Science ®Google Scholar
• Gonzalo P, Guadamillas MC, Hernández-Riquer MV, Pollán A, Grande-García A, Bartolomé RA, Vasanji A, Ambrogio C, Chiarle R, Teixidó J, et al. MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signaling. Dev Cell 2010; 18:77 - 89; http://dx.doi.org/10.1016/j.devcel.2009.11.012; PMID: 20152179
   PubMed Web of Science ®Google Scholar
• Leung R, Cuddy K, Wang Y, Rommens J, Glogauer M. Sbds is required for Rac2-mediated monocyte migration and signaling downstream of RANK during osteoclastogenesis. Blood 2011; 117:2044 - 53; http://dx.doi.org/10.1182/blood-2010-05-282574; PMID: 21084708
   PubMed Web of Science ®Google Scholar
• Leung R, Wang Y, Cuddy K, Sun C, Magalhaes J, Grynpas M, Glogauer M. Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis. J Bone Miner Res 2010; 25:1077 - 91; PMID: 19929439
   PubMed Web of Science ®Google Scholar
• Brazier H, Stephens S, Ory S, Fort P, Morrison N, Blangy A. Expression profile of RhoGTPases and RhoGEFs during RANKL-stimulated osteoclastogenesis: identification of essential genes in osteoclasts. J Bone Miner Res 2006; 21:1387 - 98; http://dx.doi.org/10.1359/jbmr.060613; PMID: 16939397
   PubMed Web of Science ®Google Scholar
• Tao W, Pennica D, Xu L, Kalejta RF, Levine AJ. Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1. Genes Dev 2001; 15:1796 - 807; http://dx.doi.org/10.1101/gad.894301; PMID: 11459829
   PubMed Web of Science ®Google Scholar
• Brazier H, Pawlak G, Vives V, Blangy A. The Rho GTPase Wrch1 regulates osteoclast precursor adhesion and migration. Int J Biochem Cell Biol 2009; 41:1391 - 401; http://dx.doi.org/10.1016/j.biocel.2008.12.007; PMID: 19135548
   PubMed Web of Science ®Google Scholar
• Saltel F, Destaing O, Bard F, Eichert D, Jurdic P. Apatite-mediated actin dynamics in resorbing osteoclasts. Mol Biol Cell 2004; 15:5231 - 41; http://dx.doi.org/10.1091/mbc.E04-06-0522; PMID: 15371537
   PubMed Web of Science ®Google Scholar
• Gil-Henn H, Destaing O, Sims NA, Aoki K, Alles N, Neff L, Sanjay A, Bruzzaniti A, De Camilli P, Baron R, et al. Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-/-) mice. J Cell Biol 2007; 178:1053 - 64; http://dx.doi.org/10.1083/jcb.200701148; PMID: 17846174
   PubMed Web of Science ®Google Scholar
• Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991; 64:693 - 702; http://dx.doi.org/10.1016/0092-8674(91)90499-O; PMID: 1997203
   PubMed Web of Science ®Google Scholar
• Qin A, Cheng TS, Pavlos NJ, Lin Z, Dai KR, Zheng MH. V-ATPases in osteoclasts: structure, function and potential inhibitors of bone resorption. Int J Biochem Cell Biol 2012; 44:1422 - 35; http://dx.doi.org/10.1016/j.biocel.2012.05.014; PMID: 22652318
   PubMed Web of Science ®Google Scholar
• Saltel F, Destaing O, Bard F, Eichert D, Jurdic P. Apatite-mediated actin dynamics in resorbing osteoclasts. Mol Biol Cell 2004; 15:5231 - 41; http://dx.doi.org/10.1091/mbc.E04-06-0522; PMID: 15371537
   PubMed Web of Science ®Google Scholar
• Ory S, Brazier H, Pawlak G, Blangy A. Rho GTPases in osteoclasts: orchestrators of podosome arrangement. Eur J Cell Biol 2008; 87:469 - 77; http://dx.doi.org/10.1016/j.ejcb.2008.03.002; PMID: 18436334
   PubMed Web of Science ®Google Scholar
• Jurdic P, Saltel F, Chabadel A, Destaing O. Podosome and sealing zone: specificity of the osteoclast model. Eur J Cell Biol 2006; 85:195 - 202; http://dx.doi.org/10.1016/j.ejcb.2005.09.008; PMID: 16546562
   PubMed Web of Science ®Google Scholar
• Luxenburg C, Geblinger D, Klein E, Anderson K, Hanein D, Geiger B, Addadi L. The architecture of the adhesive apparatus of cultured osteoclasts: from podosome formation to sealing zone assembly. PLoS One 2007; 2:e179; http://dx.doi.org/10.1371/journal.pone.0000179; PMID: 17264882
   PubMed Web of Science ®Google Scholar
• Jurdic P, Saltel F, Chabadel A, Destaing O. Podosome and sealing zone: specificity of the osteoclast model. Eur J Cell Biol 2006; 85:195 - 202; http://dx.doi.org/10.1016/j.ejcb.2005.09.008; PMID: 16546562
   PubMed Web of Science ®Google Scholar
• Chabadel A, Bañon-Rodríguez I, Cluet D, Rudkin BB, Wehrle-Haller B, Genot E, Jurdic P, Anton IM, Saltel F. CD44 and beta3 integrin organize two functionally distinct actin-based domains in osteoclasts. Mol Biol Cell 2007; 18:4899 - 910; http://dx.doi.org/10.1091/mbc.E07-04-0378; PMID: 17898081
   PubMed Web of Science ®Google Scholar
• Chellaiah MA, Kizer N, Biswas R, Alvarez U, Strauss-Schoenberger J, Rifas L, Rittling SR, Denhardt DT, Hruska KA. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol Biol Cell 2003; 14:173 - 89; http://dx.doi.org/10.1091/mbc.E02-06-0354; PMID: 12529435
   PubMed Web of Science ®Google Scholar
• McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO, Teitelbaum SL. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 2000; 105:433 - 40; http://dx.doi.org/10.1172/JCI8905; PMID: 10683372
   PubMed Web of Science ®Google Scholar
• Destaing O, Sanjay A, Itzstein C, Horne WC, Toomre D, De Camilli P, Baron R. The tyrosine kinase activity of c-Src regulates actin dynamics and organization of podosomes in osteoclasts. Mol Biol Cell 2008; 19:394 - 404; http://dx.doi.org/10.1091/mbc.E07-03-0227; PMID: 17978100
   PubMed Web of Science ®Google Scholar
• Nagai Y, Osawa K, Fukushima H, Tamura Y, Aoki K, Ohya K, Yasuda H, Hikiji H, Takahashi M, Seta Y, et al. p130Cas, Crk-associated substrate, plays important roles in osteoclastic bone resorption. J Bone Miner Res 2013; 28:2449 - 62; http://dx.doi.org/10.1002/jbmr.1936; PMID: 23526406
   PubMed Web of Science ®Google Scholar
• Faccio R, Novack DV, Zallone A, Ross FP, Teitelbaum SL. Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by beta3 integrin. J Cell Biol 2003; 162:499 - 509; http://dx.doi.org/10.1083/jcb.200212082; PMID: 12900398
   PubMed Web of Science ®Google Scholar
• Zhang D, Udagawa N, Nakamura I, Murakami H, Saito S, Yamasaki K, Shibasaki Y, Morii N, Narumiya S, Takahashi N, et al. The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts. J Cell Sci 1995; 108:2285 - 92; PMID: 7673348
   PubMed Web of Science ®Google Scholar
• Ory S, Munari-Silem Y, Fort P, Jurdic P. Rho and Rac exert antagonistic functions on spreading of macrophage-derived multinucleated cells and are not required for actin fiber formation. J Cell Sci 2000; 113:1177 - 88; PMID: 10704369
   PubMed Web of Science ®Google Scholar
• Chellaiah MA, Soga N, Swanson S, McAllister S, Alvarez U, Wang D, Dowdy SF, Hruska KA. Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem 2000; 275:11993 - 2002; http://dx.doi.org/10.1074/jbc.275.16.11993; PMID: 10766830
   PubMed Web of Science ®Google Scholar
• Destaing O, Saltel F, Gilquin B, Chabadel A, Khochbin S, Ory S, Jurdic P. A novel Rho-mDia2-HDAC6 pathway controls podosome patterning through microtubule acetylation in osteoclasts. J Cell Sci 2005; 118:2901 - 11; http://dx.doi.org/10.1242/jcs.02425; PMID: 15976449
   PubMed Web of Science ®Google Scholar
• Palazzo AF, Cook TA, Alberts AS, Gundersen GG. mDia mediates Rho-regulated formation and orientation of stable microtubules. Nat Cell Biol 2001; 3:723 - 9; http://dx.doi.org/10.1038/35087035; PMID: 11483957
   PubMed Web of Science ®Google Scholar
• Croke M, Ross FP, Korhonen M, Williams DA, Zou W, Teitelbaum SL. Rac deletion in osteoclasts causes severe osteopetrosis. J Cell Sci 2011; 124:3811 - 21; http://dx.doi.org/10.1242/jcs.086280; PMID: 22114304
   PubMed Web of Science ®Google Scholar
• Itokowa T, Zhu ML, Troiano N, Bian J, Kawano T, Insogna K. Osteoclasts lacking Rac2 have defective chemotaxis and resorptive activity. Calcif Tissue Int 2011; 88:75 - 86; http://dx.doi.org/10.1007/s00223-010-9435-3; PMID: 21110188
   PubMed Web of Science ®Google Scholar
• Magalhaes JKRS, Grynpas MD, Willett TL, Glogauer M. Deleting Rac1 improves vertebral bone quality and resistance to fracture in a murine ovariectomy model. Osteoporos Int 2011; 22:1481 - 92; http://dx.doi.org/10.1007/s00198-010-1355-6; PMID: 20683708
   PubMed Web of Science ®Google Scholar
• Goldberg SR, Georgiou J, Glogauer M, Grynpas MD. A 3D scanning confocal imaging method measures pit volume and captures the role of Rac in osteoclast function. Bone 2012; 51:145 - 52; http://dx.doi.org/10.1016/j.bone.2012.04.018; PMID: 22561898
   PubMed Web of Science ®Google Scholar
• Razzouk S, Lieberherr M, Cournot G. Rac-GTPase, osteoclast cytoskeleton and bone resorption. Eur J Cell Biol 1999; 78:249 - 55; http://dx.doi.org/10.1016/S0171-9335(99)80058-2; PMID: 10350213
   PubMed Web of Science ®Google Scholar
• Faccio R, Teitelbaum SL, Fujikawa K, Chappel J, Zallone A, Tybulewicz VL, Ross FP, Swat W. Vav3 regulates osteoclast function and bone mass. Nat Med 2005; 11:284 - 90; http://dx.doi.org/10.1038/nm1194; PMID: 15711558
   PubMed Web of Science ®Google Scholar
• Takegahara N, Kang S, Nojima S, Takamatsu H, Okuno T, Kikutani H, Toyofuku T, Kumanogoh A. Integral roles of a guanine nucleotide exchange factor, FARP2, in osteoclast podosome rearrangements. FASEB J 2010; 24:4782 - 92; http://dx.doi.org/10.1096/fj.10-158212; PMID: 20702777
   PubMed Web of Science ®Google Scholar
• Vives V, Laurin M, Cres G, Larrousse P, Morichaud Z, Noel D, Côté J-F, Blangy A. The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts. J Bone Miner Res 2011; 26:1099 - 110; http://dx.doi.org/10.1002/jbmr.282; PMID: 21542010
   PubMed Web of Science ®Google Scholar
• Sakai H, Chen Y, Itokawa T, Yu K-P, Zhu M-L, Insogna K. Activated c-Fms recruits Vav and Rac during CSF-1-induced cytoskeletal remodeling and spreading in osteoclasts. Bone 2006; 39:1290 - 301; http://dx.doi.org/10.1016/j.bone.2006.06.012; PMID: 16950670
   PubMed Web of Science ®Google Scholar
• Destaing O, Saltel F, Géminard J-C, Jurdic P, Bard F. Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein. Mol Biol Cell 2003; 14:407 - 16; http://dx.doi.org/10.1091/mbc.E02-07-0389; PMID: 12589043
   PubMed Web of Science ®Google Scholar
• Campellone KG, Welch MD. A nucleator arms race: cellular control of actin assembly. Nat Rev Mol Cell Biol 2010; 11:237 - 51; http://dx.doi.org/10.1038/nrm2867; PMID: 20237478
   PubMed Web of Science ®Google Scholar
• Ho H-YH, Rohatgi R, Lebensohn AM, Le Ma, Li J, Gygi SP, Kirschner MW. Toca-1 mediates Cdc42-dependent actin nucleation by activating the N-WASP-WIP complex. Cell 2004; 118:203 - 16; http://dx.doi.org/10.1016/j.cell.2004.06.027; PMID: 15260990
   PubMed Web of Science ®Google Scholar
• Chellaiah MA. Regulation of actin ring formation by rho GTPases in osteoclasts. J Biol Chem 2005; 280:32930 - 43; http://dx.doi.org/10.1074/jbc.M500154200; PMID: 16006560
   PubMed Web of Science ®Google Scholar
• Buck M, Xu W, Rosen MK. Global disruption of the WASP autoinhibited structure on Cdc42 binding. Ligand displacement as a novel method for monitoring amide hydrogen exchange. Biochemistry 2001; 40:14115 - 22; http://dx.doi.org/10.1021/bi0157215; PMID: 11714264
   PubMed Web of Science ®Google Scholar
• Torres E, Rosen MK. Contingent phosphorylation/dephosphorylation provides a mechanism of molecular memory in WASP. Mol Cell 2003; 11:1215 - 27; http://dx.doi.org/10.1016/S1097-2765(03)00139-4; PMID: 12769846
   PubMed Web of Science ®Google Scholar
• Ma T, Samanna V, Chellaiah MA. Dramatic inhibition of osteoclast sealing ring formation and bone resorption in vitro by a WASP-peptide containing pTyr294 amino acid. J Mol Signal 2008; 3:4; http://dx.doi.org/10.1186/1750-2187-3-4; PMID: 18289379
   PubMedGoogle Scholar
• Calle Y, Jones GE, Jagger C, Fuller K, Blundell MP, Chow J, Chambers T, Thrasher AJ. WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorption. Blood 2004; 103:3552 - 61; http://dx.doi.org/10.1182/blood-2003-04-1259; PMID: 14726392
   PubMed Web of Science ®Google Scholar
• Abdul-Manan N, Aghazadeh B, Liu GA, Majumdar A, Ouerfelli O, Siminovitch KA, Rosen MK. Structure of Cdc42 in complex with the GTPase-binding domain of the ‘Wiskott-Aldrich syndrome’ protein. Nature 1999; 399:379 - 83; http://dx.doi.org/10.1038/20726; PMID: 10360578
   PubMed Web of Science ®Google Scholar
• Rohatgi R, Ma L, Miki H, Lopez M, Kirchhausen T, Takenawa T, Kirschner MW. The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell 1999; 97:221 - 31; http://dx.doi.org/10.1016/S0092-8674(00)80732-1; PMID: 10219243
   PubMed Web of Science ®Google Scholar
• Georgess D, Mazzorana M, Terrado J, Delprat C, Chamot C, Guasch RM, Pérez-Roger I, Jurdic P, Machuca-Gayet I. Comparative transcriptomics reveals RhoE as a novel regulator of actin dynamics in bone-resorbing osteoclasts. Mol Biol Cell 2014; 25:380 - 96; http://dx.doi.org/10.1091/mbc.E13-07-0363; PMID: 24284899
   PubMed Web of Science ®Google Scholar
• Blangy A, Touaitahuata H, Cres G, Pawlak G. Cofilin activation during podosome belt formation in osteoclasts. PLoS One 2012; 7:e45909; http://dx.doi.org/10.1371/journal.pone.0045909; PMID: 23049890
   PubMedGoogle Scholar
• Lebensohn AM, Kirschner MW. Activation of the WAVE complex by coincident signals controls actin assembly. Mol Cell 2009; 36:512 - 24; http://dx.doi.org/10.1016/j.molcel.2009.10.024; PMID: 19917258
   PubMed Web of Science ®Google Scholar
• Mulari M, Vääräniemi J, Väänänen HK. Intracellular membrane trafficking in bone resorbing osteoclasts. Microsc Res Tech 2003; 61:496 - 503; http://dx.doi.org/10.1002/jemt.10371; PMID: 12879417
   PubMed Web of Science ®Google Scholar
• Itzstein C, Coxon FP, Rogers MJ. The regulation of osteoclast function and bone resorption by small GTPases. Small GTPases 2011; 2:117 - 30; http://dx.doi.org/10.4161/sgtp.2.3.16453; PMID: 21776413
   PubMedGoogle Scholar
• Zhao H, Laitala-Leinonen T, Parikka V, Väänänen HK. Downregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorption. J Biol Chem 2001; 276:39295 - 302; http://dx.doi.org/10.1074/jbc.M010999200; PMID: 11514537
   PubMed Web of Science ®Google Scholar
• Sun Y, Büki KG, Ettala O, Vääräniemi JP, Väänänen HK. Possible role of direct Rac1-Rab7 interaction in ruffled border formation of osteoclasts. J Biol Chem 2005; 280:32356 - 61; http://dx.doi.org/10.1074/jbc.M414213200; PMID: 16040606
   PubMed Web of Science ®Google Scholar
• Lacombe J, Karsenty G, Ferron M. Regulation of lysosome biogenesis and functions in osteoclasts. Cell Cycle 2013; 12:2744 - 52; http://dx.doi.org/10.4161/cc.25825; PMID: 23966172
   PubMed Web of Science ®Google Scholar
• Joberty G, Petersen C, Gao L, Macara IG. The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat Cell Biol 2000; 2:531 - 9; http://dx.doi.org/10.1038/35019573; PMID: 10934474
   PubMed Web of Science ®Google Scholar
• Nance J, Zallen JA. Elaborating polarity: PAR proteins and the cytoskeleton. Development 2011; 138:799 - 809; http://dx.doi.org/10.1242/dev.053538; PMID: 21303844
   PubMed Web of Science ®Google Scholar
• Faccio R, Teitelbaum SL, Fujikawa K, Chappel J, Zallone A, Tybulewicz VL, Ross FP, Swat W. Vav3 regulates osteoclast function and bone mass. Nat Med 2005; 11:284 - 90; http://dx.doi.org/10.1038/nm1194; PMID: 15711558
   PubMed Web of Science ®Google Scholar
• Fesik SW. Insights into programmed cell death through structural biology. Cell 2000; 103:273 - 82; http://dx.doi.org/10.1016/S0092-8674(00)00119-7; PMID: 11057900
   PubMed Web of Science ®Google Scholar
• Lee ZH, Lee SE, Kim C-W, Lee SH, Kim SW, Kwack K, Walsh K, Kim H-H. IL-1alpha stimulation of osteoclast survival through the PI 3-kinase/Akt and ERK pathways. J Biochem 2002; 131:161 - 6; http://dx.doi.org/10.1093/oxfordjournals.jbchem.a003071; PMID: 11754748
   PubMed Web of Science ®Google Scholar
• Lee SE, Chung WJ, Kwak HB, Chung CH, Kwack KB, Lee ZH, Kim HH. Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK. J Biol Chem 2001; 276:49343 - 9; http://dx.doi.org/10.1074/jbc.M103642200; PMID: 11675379
   PubMed Web of Science ®Google Scholar
• Gingery A, Bradley E, Shaw A, Oursler MJ. Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFkappaB pathways to maintain osteoclast survival. J Cell Biochem 2003; 89:165 - 79; http://dx.doi.org/10.1002/jcb.10503; PMID: 12682917
   PubMed Web of Science ®Google Scholar
• Fukuda A, Hikita A, Wakeyama H, Akiyama T, Oda H, Nakamura K, Tanaka S. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1. J Bone Miner Res 2005; 20:2245 - 53; http://dx.doi.org/10.1359/JBMR.050816; PMID: 16294277
   PubMed Web of Science ®Google Scholar
• Armas LAG, Recker RR. Pathophysiology of osteoporosis: new mechanistic insights. Endocrinol Metab Clin North Am 2012; 41:475 - 86; http://dx.doi.org/10.1016/j.ecl.2012.04.006; PMID: 22877425
   PubMed Web of Science ®Google Scholar
• Chen Y-C, Sosnoski DM, Mastro AM. Breast cancer metastasis to the bone: mechanisms of bone loss. Breast Cancer Res 2010; 12:215; http://dx.doi.org/10.1186/bcr2781; PMID: 21176175
   PubMed Web of Science ®Google Scholar
• Russell RGG. Bisphosphonates: the first 40 years. Bone 2011; 49:2 - 19; http://dx.doi.org/10.1016/j.bone.2011.04.022; PMID: 21555003
   PubMed Web of Science ®Google Scholar
• Giger EV, Castagner B, Leroux J-C. Biomedical applications of bisphosphonates. J Control Release 2013; 167:175 - 88; http://dx.doi.org/10.1016/j.jconrel.2013.01.032; PMID: 23395668
   PubMed Web of Science ®Google Scholar
• Luckman SP, Coxon FP, Ebetino FH, Russell RG, Rogers MJ. Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structure-activity relationships in J774 macrophages. J Bone Miner Res 1998; 13:1668 - 78; http://dx.doi.org/10.1359/jbmr.1998.13.11.1668; PMID: 9797474
   PubMed Web of Science ®Google Scholar
• van Beek E, Pieterman E, Cohen L, Löwik C, Papapoulos S. Nitrogen-containing bisphosphonates inhibit isopentenyl pyrophosphate isomerase/farnesyl pyrophosphate synthase activity with relative potencies corresponding to their antiresorptive potencies in vitro and in vivo. Biochem Biophys Res Commun 1999; 255:491 - 4; http://dx.doi.org/10.1006/bbrc.1999.0224; PMID: 10049736
   PubMed Web of Science ®Google Scholar
• Coxon FP, Helfrich MH, Van’t Hof R, Sebti S, Ralston SH, Hamilton A, Rogers MJ. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Miner Res 2000; 15:1467 - 76; http://dx.doi.org/10.1359/jbmr.2000.15.8.1467; PMID: 10934645
   PubMed Web of Science ®Google Scholar
• Dunford JE, Rogers MJ, Ebetino FH, Phipps RJ, Coxon FP. Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases. J Bone Miner Res 2006; 21:684 - 94; http://dx.doi.org/10.1359/jbmr.060118; PMID: 16734383
   PubMed Web of Science ®Google Scholar
• Luckman SP, Hughes DE, Coxon FP, Graham R, Russell G, Rogers MJ. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 1998; 13:581 - 9; http://dx.doi.org/10.1359/jbmr.1998.13.4.581; PMID: 9556058
   PubMed Web of Science ®Google Scholar
• Agarwal P, Rao NN. Bisphosphonate-associated osteonecrosis of the jaws. Indian J Dent Res 2012; 23:107 - 11; http://dx.doi.org/10.4103/0970-9290.99051; PMID: 22842261
   PubMedGoogle Scholar
• Hirschberg R. Renal complications from bisphosphonate treatment. Curr Opin Support Palliat Care 2012; 6:342 - 7; http://dx.doi.org/10.1097/SPC.0b013e328356062e; PMID: 22710581
   PubMed Web of Science ®Google Scholar
• Lotinun S, Kiviranta R, Matsubara T, Alzate JA, Neff L, Lüth A, Koskivirta I, Kleuser B, Vacher J, Vuorio E, et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J Clin Invest 2013; 123:666 - 81; PMID: 23321671
   PubMed Web of Science ®Google Scholar
• Motyckova G, Fisher DE. Pycnodysostosis: role and regulation of cathepsin K in osteoclast function and human disease. Curr Mol Med 2002; 2:407 - 21; http://dx.doi.org/10.2174/1566524023362401; PMID: 12125807
   PubMedGoogle Scholar
• Chapurlat RD. Odanacatib for the treatment of postmenopausal osteoporosis. Expert Opin Pharmacother 2014; 15:97 - 102; http://dx.doi.org/10.1517/14656566.2014.853038; PMID: 24156249
   PubMed Web of Science ®Google Scholar
• Stoch SA, Zajic S, Stone JA, Miller DL, van Bortel L, Lasseter KC, Pramanik B, Cilissen C, Liu Q, Liu L, et al. Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics--results from single oral dose studies in healthy volunteers. Br J Clin Pharmacol 2013; 75:1240 - 54; http://dx.doi.org/10.1111/j.1365-2125.2012.04471.x; PMID: 23013236
   PubMed Web of Science ®Google Scholar
• Brixen K, Chapurlat R, Cheung AM, Keaveny TM, Fuerst T, Engelke K, Recker R, Dardzinski B, Verbruggen N, Ather S, et al. Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial. J Clin Endocrinol Metab 2013; 98:571 - 80; http://dx.doi.org/10.1210/jc.2012-2972; PMID: 23337728
   PubMed Web of Science ®Google Scholar
• Engelke K, Nagase S, Fuerst T, Small M, Kuwayama T, Deacon S, Eastell R, Genant H-K. The effect of the cathepsin K inhibitor ONO-5334 on trabecular and cortical bone in postmenopausal osteoporosis: The OCEAN study. J Bone Miner Res 2014; 29:629 - 38; http://dx.doi.org/10.1002/jbmr.2080; PMID: 24038152
   PubMed Web of Science ®Google Scholar
• Eastell R, Nagase S, Small M, Boonen S, Spector T, Ohyama M, Kuwayama T, Deacon S. Effect of ONO-5334 on bone mineral density and biochemical markers of bone turnover in postmenopausal osteoporosis: 2-year results from the OCEAN study. J Bone Miner Res 2014; 29:458 - 66; http://dx.doi.org/10.1002/jbmr.2047; PMID: 23873670
   PubMed Web of Science ®Google Scholar